Figure 1. Kaplan-Meier analysis of progression-free survival for 6 MRD negative (<10-6) and 10 MRD positive (>10-6) patients.
Figure 1.

Kaplan-Meier analysis of progression-free survival for 6 MRD negative (<10-6) and 10 MRD positive (>10-6) patients.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal